Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Bacterial DNA-directed RNA polymerase; structurally similar to both tirandamycin and streptolydigin. Potent against a number of anaerobes.